Zeiss Light and Electron Microscopy Combined in New Business Group
By LabMedica International staff writers Posted on 28 Nov 2011 |
The Carl Zeiss Group (Gottingen, Germany) has launched a new microscopy business group that combines microimaging and nanotechnology systems. In the future, the company will be the world's only supplier to offer one-stop, innovative systems, and solutions for light and electron microscopy.
Customers are increasingly using both systems and want integrated software and workflow solutions. The combination of Carl Zeiss MicroImaging and Nanotechnology Systems into one business group fully reflects this trend.
"By fusing the two worlds of microscopy, we are opening up totally new perspectives to our customers in science and industry," says Dr. Ulrich Simon, head of Carl Zeiss Microscopy. "Carl Zeiss has been a pioneer in this field for more than 160 years. Carl Zeiss and Ernst Abbe together invented scientific microscopy more than 160 years ago. Since then, the company has constantly played a crucial role in shaping the progress of this technology. We are now opening an exciting new chapter in this success story."
The potential offered by combining light and electron microscopy is illustrated by Prof. Jeff Lichtman of Harvard University (Cambridge, MA, USA), who is pioneering brain mapping with light and electron microscopy by generating three-dimensional maps of the brain.
Competition is increasing all over the world: microscopy is a fast-growing market because it is increasingly developing into a basic technology that is now firmly established in many different fields. It is a market that is characterized by big providers and small specialists for specific technologies. The new Carl Zeiss Microscopy business group combines two strengths: it has the right size to carry clout and offers technological expertise covering the entire microscopy process.
Related Links:
Carl Zeiss Group
Harvard University
Customers are increasingly using both systems and want integrated software and workflow solutions. The combination of Carl Zeiss MicroImaging and Nanotechnology Systems into one business group fully reflects this trend.
"By fusing the two worlds of microscopy, we are opening up totally new perspectives to our customers in science and industry," says Dr. Ulrich Simon, head of Carl Zeiss Microscopy. "Carl Zeiss has been a pioneer in this field for more than 160 years. Carl Zeiss and Ernst Abbe together invented scientific microscopy more than 160 years ago. Since then, the company has constantly played a crucial role in shaping the progress of this technology. We are now opening an exciting new chapter in this success story."
The potential offered by combining light and electron microscopy is illustrated by Prof. Jeff Lichtman of Harvard University (Cambridge, MA, USA), who is pioneering brain mapping with light and electron microscopy by generating three-dimensional maps of the brain.
Competition is increasing all over the world: microscopy is a fast-growing market because it is increasingly developing into a basic technology that is now firmly established in many different fields. It is a market that is characterized by big providers and small specialists for specific technologies. The new Carl Zeiss Microscopy business group combines two strengths: it has the right size to carry clout and offers technological expertise covering the entire microscopy process.
Related Links:
Carl Zeiss Group
Harvard University
Latest Industry News
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus